Beating Bone Marrow Cancer

Hematologists Boost Immune

Response in Bone-Marrow

Transplant Patients

March 1, 2006 — To lessen the impact of chemotherapy on bone marrow cancer patients, hematologists are recruiting the patients’ own immune systems to help. White blood cells are extracted before a bone marrow transplant, treated to up their activity, and injected back after chemotherapy. Doctors hope to test technique on other patients with immune deficiencies, including HIV.

BALTIMORE–A heavy dose of chemo takes a huge toll on cancer patients’ bodies, making them weak and prone to infection. Now, a new, life-saving therapy is helping some cancer patients win the war against a deadly disease.

Having bone marrow cancer hasn’t slowed down Todd Ewell, but the chemotherapy to fight the disease stopped him in his tracks. “It’s kind of like if you had the worst flu in your life for about six weeks straight,” he says.

The body’s immune system takes a beating from chemotherapy. Patients can’t fight off infection or disease, but Todd’s body fought back, thanks to a new immune-boosting therapy.

Aaron Rapoport, a hematologist and oncologist at the University of Maryland Greenebaum Cancer Center in Baltimore, says, “What we’re seeking to do is to harness the power of the patient’s own immune system.”

Before a bone marrow transplant, hematologists collect a patient’s own immune cells, then activate, or turn on, the cells in a lab. The enhanced cells are injected back into the patient, along with a pneumonia vaccine, jump-starting the immune system. “It will be better able to respond to infections and also be better able to attack and eliminate cancer cells that may remain,” Dr. Rapoport tells DBIS.

The new therapy worked wonders for Todd. “It’s going fantastic. It’s almost like it never happened.” His cancer is in complete remission, and now he’s focused on rebuilding his life cancer free.

Doctors are hopeful the new therapy could be tested and used to treat other people with compromised immune systems liked HIV patients and the elderly.

BACKGROUND: A new form of immunotherapy combines a vaccine with an infusion of a person’s own T-cells that have been given a “jump start” and then are grown in the laboratory. The new approach helps to restore cancer patients’ ability to fight off infection after high-dose chemotherapy. It could also one day be used to treat others with compromised immune systems, such as those with HIV and the elderly.

THE STUDY: Patients with advanced myeloma, a cancer of the plasma cells in the bone marrow, received high-dose chemotherapy and a bone marrow transplant. They received a series of vaccinations against a common bacterial form of pneumonia as well as an injection of their own lab-enhanced immune cells. Researchers found the therapy was most effective when patients received vaccinations before the bone marrow transplant to jump-start their immune system, and then collected the “vaccine-primed” T cells, activated them in the lab, and gave them back to the patients 12 days after the transplant. Within one month, those patients showed significant improvement in their immune response. The researchers will next combine this T-cell therapy with a cancer vaccine that would target tumor cells, hopefully to one day enhance the body’s immune response to cancer.

WHAT IS IMMUNOTHERAPY? A slow or non-functioning immune system is a serious problem for cancer patients, especially those who receive intensive chemotherapy prior to bone marrow transplants. Patients are at high risk of developing infections and recurrence of their cancer. Immunotherapy stimulates a patient’s own immune system to work harder. It’s often used in conjunction with other forms of therapy — in the case of cancer, it is combined with surgery, radiation therapy, or chemotherapy. In general, immunotherapy is most likely to be effective when treating small cancers and is less effective for advanced stages of the disease.

WHAT ARE T-CELLS? T-cells are a type of white blood cell called lymphocytes, and help the immune system fight off diseases. There are two kinds of T-cells. T4 cells are “helper” cells that lead the attack against infections. T8 cells are “suppressor cells” that end the immune response, although they can also kill cancer cells and cells infected with a virus. Scientists tell T4 and T8 cells apart by the different proteins attached to the outside of each cell. The number of T4 cells in your blood tells you how healthy your immune system is. A person with a healthy immune system has an average T-cell percentage of more than 30 percent.

ABOUT CHEMOTHERAPY: Chemotherapy is a treatment for cancer, in which certain drugs (poisonous to cancer cells) are injected into the blood to kill cancer cells or to stop them from spreading. They can travel around the body and attack cancer cells wherever they find them, so chemotherapy is used when cancers have spread beyond one region of the body.

Editor’s Note: This article is not intended to provide medical advice, diagnosis or treatment.

Sourced & published by Henry Sapiecha

Tags: , , , , ,

Leave a Reply